Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Mol Sci ; 21(23)2020 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-33271955

RESUMO

We evaluated the mechanisms underlying the oxytocin (OXT)-induced analgesic effect on orofacial neuropathic pain following infraorbital nerve injury (IONI). IONI was established through tight ligation of one-third of the infraorbital nerve thickness. Subsequently, the head withdrawal threshold for mechanical stimulation (MHWT) of the whisker pad skin was measured using a von Frey filament. Trigeminal ganglion (TG) neurons innervating the whisker pad skin were identified using a retrograde labeling technique. OXT receptor-immunoreactive (IR), transient receptor potential vanilloid 1 (TRPV1)-IR, and TRPV4-IR TG neurons innervating the whisker pad skin were examined on post-IONI day 5. The MHWT remarkably decreased from post-IONI day 1 onward. OXT application to the nerve-injured site attenuated the decrease in MHWT from day 5 onward. TRPV1 or TRPV4 antagonism significantly suppressed the decrement of MHWT following IONI. OXT receptors were expressed in the uninjured and Fluoro-Gold (FG)-labeled TG neurons. Furthermore, there was an increase in the number of FG-labeled TRPV1-IR and TRPV4-IR TG neurons, which was inhibited by administering OXT. This inhibition was suppressed by co-administration with an OXT receptor antagonist. These findings suggest that OXT application inhibits the increase in TRPV1-IR and TRPV4-IR TG neurons innervating the whisker pad skin, which attenuates post-IONI orofacial mechanical allodynia.


Assuntos
Traumatismos dos Nervos Cranianos/complicações , Neuralgia Facial/etiologia , Neuralgia Facial/metabolismo , Neurônios/metabolismo , Ocitocina/administração & dosagem , Canais de Potencial de Receptor Transitório/genética , Gânglio Trigeminal/metabolismo , Animais , Modelos Animais de Doenças , Neuralgia Facial/diagnóstico , Imunofluorescência , Regulação da Expressão Gênica/efeitos dos fármacos , Limiar da Dor/efeitos dos fármacos , Ratos , Receptores de Ocitocina/genética , Receptores de Ocitocina/metabolismo , Canais de Potencial de Receptor Transitório/metabolismo
2.
J Dent Res ; 92(5): 456-60, 2013 May.
Artigo em Inglês | MEDLINE | ID: mdl-23520364

RESUMO

The exact mechanism underlying chronic masseter muscle pain, a conspicuous symptom in temporomandibular disorder, remains unclear. We investigated whether expression of P2X3 receptor (P2X3R) is involved in mechanical hyperalgesia after contraction of masseter muscle (CMM). As compared with sham rats, the head-withdrawal threshold (HWT) to mechanical pressure stimulation of masseter muscle (MM) (but not after similar stimulation of facial skin) was significantly lower, and IL-1ß level was significantly higher, in CMM rats on day 7 after CMM. The mean percentage of FG-labeled P2X3R-positive neurons was significantly increased in TG following successive IL-1ß injections into the MM for 7 days. Successive administration of an IL-1ß receptor-antagonist into the MM attenuated the increase of P2X3-IR cells in the TG. ATP release from MM after 300-g pressure stimulation of MM was also significantly enhanced after CMM. Administration into MM of the selective P2X3,2/3 receptor antagonist A-317491 attenuated the decrement of HWT in CMM rats. A significant increase in HWT was also observed at 30 min after A-317491 (60 µg) injection in IL-1ß-injected rats. These findings suggest that P2X3R expression associated with enhanced IL-1ß expression and ATP release in MM has a possible important role in MM mechanical hyperalgesia after excessive muscular contraction.


Assuntos
Neuralgia Facial/metabolismo , Interleucina-1beta/metabolismo , Músculo Masseter/metabolismo , Contração Muscular/fisiologia , Receptores Purinérgicos P2X3/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Estimulação Elétrica , Neuralgia Facial/complicações , Neuralgia Facial/fisiopatologia , Hiperalgesia/complicações , Hiperalgesia/metabolismo , Hiperalgesia/fisiopatologia , Masculino , Músculo Masseter/fisiopatologia , Antagonistas do Receptor Purinérgico P2X/farmacocinética , Ratos , Ratos Sprague-Dawley , Tempo de Reação/fisiologia , Receptores de Interleucina/antagonistas & inibidores , Receptores Purinérgicos P2X3/efeitos dos fármacos , Síndrome da Disfunção da Articulação Temporomandibular/complicações , Síndrome da Disfunção da Articulação Temporomandibular/metabolismo , Síndrome da Disfunção da Articulação Temporomandibular/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...